Anesthesiology Doctors in Moses Lake, WA Accepting Medicare

3 Anesthesiology doctors found. Showing 1 - 3

Derek Cord Mitchell, MD Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 S Pioneer Way, Moses Lake, WA 98837 Phone: 509-793-9733    Fax: 509-764-3279

Dr. M. Lyndon Dieter, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 801 E Wheeler Rd, Moses Lake, WA 98837 Phone: 509-765-5606    Fax: 509-764-3244

Blair Mercer Barnett, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 801 E Wheeler Rd, Moses Lake, WA 98837 Phone: 800-204-0099    Fax: 336-882-2216

News Archive

News organizations offer last minute decoders for health debate

Media organizations have presented a variety of health care decoders today, in anticipation of President Obama's speech tonight. Timelines, glossaries and a list of interest groups' ambitions seek to put the debate in context.

Study finds a sharp decline in heart transplants during the pandemic

The number of heart transplants in the United States declined sharply during the beginning of the pandemic, even in areas of the country with few COVID-19 cases at the time, according to an analysis by researchers at Columbia University Irving Medical Center.

SurgLine to deliver first surgical instrumentation products to Denver hospital system

China Nuvo Solar Energy, Inc. today announced that its wholly owned subsidiary, SurgLine will deliver its first surgical instrumentation products to one of Denver's largest acute care hospital systems for use by one of its outpatient surgery centers.

Number of children contracting SARS-CoV-2 steadily increasing, CDC says

The U.S. Centers for Disease Control and Prevention (CDC) released new guidance revealing that the number and infection rate of COVID-19 cases among children have steadily increased between March and July, which may worsen as schools start to re-open.

AEterna Zentaris terminates its agreement on cetrorelix with sanofi-aventis U.S.

AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the termination of its agreement with sanofi-aventis U.S. ( SNY) dated March 5, 2009 for the development, commercialization and licensing of cetrorelix in benign prostatic hyperplasia (BPH) for the U.S. market, following the Company's announcement last week of the results for its European Phase 3 study for cetrorelix in BPH.

Read more Medical News

› Verified 7 days ago